Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Active not recruiting 3Unknown 2Recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 4Gynecologic 3Other solid neoplasm 2Other hematologic neoplasm 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Primary Ovarian Insufficiency 1Hereditary Breast and Ovarian Cancer Syndrome 1Endometrial Neoplasms 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Genetic Testing × Gynecologic × Clear all
NCT03731845 2025-11-20

ESIGON

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting
73 enrolled
BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT05591131 2025-02-21

GTM-I

Augusta University

Phase NA Active not recruiting
21 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT03246841 2024-12-12

TUMOSPEC

UNICANCER

Phase NA Active not recruiting
7,274 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡